StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$45.01M. The highest annual figure on record is -$25.08M in fiscal 2023.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$45.01M–
FY2024Dec 31, 2024-$39.62M–
FY2023Dec 31, 2023-$25.08M–
FY2022Dec 31, 2022-$34.03M–
FY2021Dec 31, 2021-$41.52M–
FY2020Dec 31, 2020-$52.78M–

More CASI Pharmaceuticals figures

See a number that looks wrong?